Canadian Hospital Specialties Ltd. Revenue and Competitors
Estimated Revenue & Valuation
- Canadian Hospital Specialties Ltd.'s estimated annual revenue is currently $64M per year.
- Canadian Hospital Specialties Ltd.'s estimated revenue per employee is $251,000
Employee Data
- Canadian Hospital Specialties Ltd. has 255 Employees.
- Canadian Hospital Specialties Ltd. grew their employee count by 42% last year.
Canadian Hospital Specialties Ltd. Competitors & Alternatives
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $29.6M | 118 | 11% | N/A | N/A |
#2 | $5.3M | 21 | 31% | N/A | N/A |
#3 | $66.3M | 264 | 6% | N/A | N/A |
#4 | $19.1M | 76 | 29% | N/A | N/A |
#5 | $5.8M | 23 | 5% | N/A | N/A |
#6 | $219.4M | 874 | 13% | N/A | N/A |
#7 | $36.6M | 0 | N/A | $1.3B | N/A |
#8 | $33.4M | 133 | 13% | N/A | N/A |
#9 | $9.8M | 39 | 18% | N/A | N/A |
#10 | $40.2M | 160 | 26% | N/A | N/A |
What Is Canadian Hospital Specialties Ltd.?
Canadian Hospital Specialties Ltd. (CHS) is a leading national specialty distributor of medical/surgical supplies. Our extensive product portfolio spans across many hospital call points and programs including; Anesthesia, Cardiac, Vascular & General Surgery, Interventional Radiology, Cardiology & Diagnostic Imaging, Critical Care and the NICU. As well, CHS supports an extensive network of over 300 active alternate care dealers and pharmacies throughout Canada to reach the fast-growing home care market. Our clinical, sales and marketing expertise along with continued investment in new technologies, has allowed CHS to partner with many of the leading companies in Healthcare today.
keywords:N/AN/A
Total Funding
255
Number of Employees
$64M
Revenue (est)
42%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $99.4M | 256 | 24% | N/A |
#2 | $15M | 266 | -2% | N/A |
#3 | $60.4M | 268 | -5% | N/A |
#4 | $105.6M | 313 | N/A | N/A |
#5 | $35M | 353 | N/A | N/A |